Lenzetto® is indicated as HRT for oestrogen deficiency symptoms in postmenopausal woman
(women at least 6 months since their last menses or surgical menopause, with or without a uterus).
There is limited experience in treating women older than 65 years.1
As an invisible, quick-drying HRT spray,
Lenzetto® relieves oestrogen deficiency symptoms
in menopausal women starting HRT1–3
-
Transdermal preparation
avoiding first-pass
liver metabolism -
Unique
spray design* -
Accurate dosage
which can be titrated
up or down where
necessary -
Dries in around
2 minutes -
Invisible
drug application -
The drug application
area remains dry
with no residue -
The drug application
area can be washed
after 1 hour
Transdermal preparation
Unique
Accurate dosage
Dries in around
Invisible
The drug application
The drug application
Lenzetto® is proudly made by Gedeon Richter.
We aim to operate with high stock levels for Lenzetto® and all our other products.
All stages in the production of Lenzetto® are managed in-house across our own sites in Europe.
*Lenzetto® has not been determined as superior to other HRT formulations. Here, unique is used to describe the fact that Lenzetto® is currently the only HRT with a spray design.